evocatal invests in high-throughput technology and multiplies its screening capacity
The evocatal GmbH puts its new high-throughput screening lab located in the Life-Science Centre Duesseldorf into operation. The company multiplies its capacity for the development of new enzymes with this step. Accordingly the time-to-market period is significantly shortened through automization.
Together with the scientific advisory board and evocatal’s 17-strong team CSO Dr. Christian Leggewie opens up the newly established high-throughput laboratory in the Life Science Centre Duesseldorf.
The investment enables evocatal to reduce development periods for customized biocatalysts immensely. This applies for projects with cooperation partners as well as for supplying efficient enzymes for the internal production of fine chemicals.
Other news from the department business & finance

Get the life science industry in your inbox
By submitting this form you agree that LUMITOS AG will send you the newsletter(s) selected above by email. Your data will not be passed on to third parties. Your data will be stored and processed in accordance with our data protection regulations. LUMITOS may contact you by email for the purpose of advertising or market and opinion surveys. You can revoke your consent at any time without giving reasons to LUMITOS AG, Ernst-Augustin-Str. 2, 12489 Berlin, Germany or by e-mail at revoke@lumitos.com with effect for the future. In addition, each email contains a link to unsubscribe from the corresponding newsletter.
Most read news
More news from our other portals
Last viewed contents
Model may offer better understanding of embryonic development
Proteus_OX19
Category:Schizophrenia
Bothrops_asper
Applied Biosystems and Asuragen collaborate with the Critical Path Institute to improve drug toxicity screening
Hepatitis B and C Public Policy Association ASBL - Luxemburg, Luxembourg
Category:Veterinary_entomology
Mission_malawi

Separating Drugs with MagLev - Magneto-Archimedes levitation for identification of illicit drugs in powdered mixtures

Dust mite allergens trigger inflammatory responses - Dust mite allergens activate the pulmonary immune system, thereby triggering allergies
Biological testing tool tests in fraction of time of industry standard
